Literature DB >> 17554006

Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia.

Oxana Baranova1, Luis F Miranda, Paola Pichiule, Ioannis Dragatsis, Randall S Johnson, Juan C Chavez.   

Abstract

In the present study, we show a biphasic activation of hypoxia inducible factor 1alpha (HIF-1) after stroke that lasts for up to 10 d, suggesting the involvement of the HIF pathway in several aspects of the pathophysiology of cerebral ischemia. We provide evidence that HIF-1-mediated responses have an overall beneficial role in the ischemic brain as indicated by increased tissue damage and reduced survival rate of mice with neuron-specific knockdown of HIF-1alpha that were subjected to transient focal cerebral ischemia. In addition, we demonstrated that drugs known to activate HIF-1 in cultured cells as well as in vivo had neuroprotective properties in this model of cerebral ischemia. This protective effect was significantly attenuated but not completely abolished in neuron-specific HIF-1alpha-deficient mice, suggesting that alternative mechanisms of neuroprotection are also implicated. Last, our study showed that hypoxia-induced tolerance to ischemia was preserved in neuron-specific HIF-1alpha-deficient mice, indicating that the neuroprotective effects of hypoxic preconditioning do not depend on neuronal HIF-1 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554006      PMCID: PMC6672155          DOI: 10.1523/JNEUROSCI.0449-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion.

Authors:  T N Lin; C K Wang; W M Cheung; C Y Hsu
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

3.  CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain.

Authors:  I Dragatsis; S Zeitlin
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

4.  Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.

Authors:  M Bergeron; A Y Yu; K E Solway; G L Semenza; F R Sharp
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

5.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Authors:  H J Marti; M Bernaudin; A Bellail; H Schoch; M Euler; E Petit; W Risau
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

6.  Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain.

Authors:  O O Ogunshola; W B Stewart; V Mihalcik; T Solli; J A Madri; L R Ment
Journal:  Brain Res Dev Brain Res       Date:  2000-01-03

Review 7.  Multiple molecular penumbras after focal cerebral ischemia.

Authors:  F R Sharp; A Lu; Y Tang; D E Millhorn
Journal:  J Cereb Blood Flow Metab       Date:  2000-07       Impact factor: 6.200

8.  Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.

Authors:  K Zaman; H Ryu; D Hall; K O'Donovan; K I Lin; M P Miller; J C Marquis; J M Baraban; G L Semenza; R R Ratan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

9.  Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia.

Authors:  R K Bruick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

View more
  150 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

3.  Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats.

Authors:  Jae Hoon Lee; Hui Song Cui; Seo Kyung Shin; Jeong Min Kim; So Yeon Kim; Jong Eun Lee; Bon-Nyeo Koo
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

Review 4.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 5.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

Review 6.  Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.

Authors:  David Brand; Rajiv R Ratan
Journal:  Transl Stroke Res       Date:  2013-01-08       Impact factor: 6.829

7.  Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.

Authors:  Rhonda Souvenir; Jerry J Flores; Robert P Ostrowski; Anatol Manaenko; Kamil Duris; Jiping Tang
Journal:  Transl Stroke Res       Date:  2013-11-27       Impact factor: 6.829

8.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

Review 9.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

10.  In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation.

Authors:  Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Thong C Ma; Rachel E Speer; Natalya A Smirnova; Irina G Gazaryan; Rajiv R Ratan
Journal:  J Neurosci Res       Date:  2013-03-04       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.